PharmaShots | Incisive News in 3 Shots

Subscribe Now

Abbott

Abbott Reports Results of MitraClip & TriClip Device in Multiple Studies for the Treatment of Patients with Heart Failure

Abbott Reports Results of MitraClip & TriClip Device in Multiple Studies for the Treatment of Patients with Heart Failure

June 9, 2022

Abbott’s FreeStyle Libre 3 System Receives the US FDA’s Clearance for the Treatment of Diabetes

Abbott’s FreeStyle Libre 3 System Receives the US FDA’s Clearance for the Treatment of Diabetes

June 1, 2022

Abbott Presents Results of TriClip Device and Navitor TAVI System for Tricuspid Regurgitation & Aortic Stenosis at EuroPCR 2022

Abbott Presents Results of TriClip Device and Navitor TAVI System for Tricuspid Regurgitation & Aortic Stenosis at EuroPCR 2022

May 20, 2022

Abbott Reports Results of TactiCath SE in (PERSIST-END) Study for the Treatment of Persistent Atrial Fibrillation

Abbott Reports Results of TactiCath SE in (PERSIST-END) Study for the Treatment of Persistent Atrial Fibrillation

May 2, 2022

Abbott Launches Amplatzer Steerable Delivery Sheath for Amulet Device to Treat Atrial Fibrillation

Abbott Launches Amplatzer Steerable Delivery Sheath for Amulet Device to Treat Atrial Fibrillation

April 29, 2022

Abbott Launches Upgraded Version of NeuroSphere myPath Digital Health App to Boost Connected Care Technology for Chronic Pain

Abbott Launches Upgraded Version of NeuroSphere myPath Digital Health App to Boost Connected Care Technology for Chronic Pain

April 26, 2022

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us